Bedel Financial Consulting, Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1730511 INDIANAPOLIS, IN

Position in GILD

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$203,028

-$20,800 QoQ

Shares Held

1,607

+0.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#1,909

of 2,266 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Bedel Financial Consulting, Inc. holds $404,013,991 across 11 Drug Manufacturers - General names. GILD ranks #11 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	328,198	$393,650,559
2	JNJ	Johnson & Johnson	13,084	$3,322,943
3	ABBV	AbbVie Inc.	11,757	$2,958,531
4	MRK	Merck & Co., Inc.	7,015	$901,427
5	PFE	Pfizer Inc	31,588	$760,639
6	NVS	Novartis AG	4,326	$677,970
7	AMGN	Amgen Inc	1,648	$596,773
8	GSK	GSK plc	7,562	$396,400

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$203,028	1,607	+0.1%	Shares	Sole	2026-07-29
2026-03-31	$223,828	1,606	-10.2%	Shares	Sole	2026-05-04
2022-03-31	$106,356	1,789	+8.6%	Shares	Sole	2022-04-19
2021-12-31	$119,661	1,648	+0.1%	Shares	Other	2022-01-11
2021-09-30	$115,042	1,647	0.0%	Shares	Sole	2021-10-12
2021-06-30	$113,412	1,647	-25.8%	Shares	Sole	2021-08-03
2021-03-31	$143,478	2,220	+587.3%	Shares	Sole	2021-04-26
2020-12-31	$18,817	323	-23.6%	Shares	Sole	2021-02-02
2020-09-30	$26,729	423	+31.0%	Shares	Sole	2020-10-20
2020-06-30	$24,851	323	-1.8%	Shares	Sole	2020-07-14
2020-03-31	$24,596	329	—	Shares	Sole	2020-05-06
No filing history on record for this holder in this stock.